Podcasts Health & Fitness Medicine Oncology Times - OncTimes Talk CML: Hagop Kantarjian on Treating Patients with the T315I Mutation

CML: Hagop Kantarjian on Treating Patients with the T315I Mutation

Published: July 21, 2009, 6:32 p.m.

Also: (1) Feasibility of patients becoming pregnant while having TKI treatment after having stable disease for at least two years; and (2) Decreased need for allogeneic transplant.